With competition in the GLP-1 category increasingly cutthroat, Novo Nordisk has latched onto a real-world study that found its weight-loss drug Wegovy was better than Eli Lilly's rival Zepbound at ...
New and revised clinical guidance spanning dyslipidemia, cardiovascular disease in pregnancy, valvular heart disease, myocarditis and pericarditis, and mental health was released as part of ESC ...
Beta-blocker therapy following myocardial infarction (MI) was the primary focus of a hot line session at ESC Congress 2025. Study investigators presented findings from the REBOOT-CNIC and ...
The Collective Complaints procedure was introduced by the Additional Protocol providing for a system of collective complaints, adopted in 1995. The aim pursued with the introduction of the procedure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback